Your browser doesn't support javascript.
Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era.
Hamdy, Sherif M; Abdel-Naseer, Maged; Shehata, Hatem S; Shalaby, Nevin M; Hassan, Amr; Elmazny, Alaa; Shaker, Ehab; Nada, Mona A F; Ahmed, Sandra M; Hegazy, Mohamed I; Mourad, Husam S; Abdelalim, Ahmed; Magdy, Rehab; Othman, Alshimaa S; Mekkawy, Doaa A; Kishk, Nirmeen A.
  • Hamdy SM; Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Abdel-Naseer M; Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Shehata HS; Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Shalaby NM; Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Hassan A; Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Elmazny A; Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Shaker E; Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Nada MAF; Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Ahmed SM; Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Hegazy MI; Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Mourad HS; Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Abdelalim A; Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Magdy R; Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Othman AS; Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Mekkawy DA; Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Kishk NA; Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Ther Clin Risk Manag ; 16: 759-767, 2020.
Article in English | MEDLINE | ID: covidwho-732942
ABSTRACT
The ongoing coronavirus (COVID-19) pandemic is a global health emergency of international concern and has affected management plans of many autoimmune disorders. Immunosuppressive and immunomodulatory therapies are pivotal in the management of neuromyelitis optica spectrum disorder (NMOSD), potentially placing patients at an increased risk of contracting infections such as COVID-19. The optimal management strategy of NMOSD during the COVID-19 era remains unclear. Here, however, we examined the evidence of NMOSD disease-modifying therapies (DMTs) use during the present period and highlighted different scenarios including treatment of relapses as well as initiation and maintenance of DMTs in order to optimize care of NMOSD patients in the COVID-19 era.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Ther Clin Risk Manag Year: 2020 Document Type: Article Affiliation country: Tcrm.S261753

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Ther Clin Risk Manag Year: 2020 Document Type: Article Affiliation country: Tcrm.S261753